Related Experiment Videos
Teenagers with diabetes--management challenges
1Department of Endocrinology and Diabetes, Royal Children's Hospital, University of Melbourne, Victoria. fergus.cameron@rch.org.au
Australian Family Physician
|June 6, 2006
Summary
Adolescent type 1 diabetes management is challenging due to hormonal changes and a desire for independence. Healthcare providers should foster supportive relationships and encourage family involvement for better metabolic control.
Area of Science:
- Pediatric Endocrinology
- Adolescent Medicine
- Metabolic Disorders
Background:
- Adolescence involves significant hormonal, neuro-maturational, emotional, and psychosocial changes.
- Managing chronic conditions like type 1 diabetes during this period presents unique challenges.
- Instability can be exacerbated by the demands of diabetes care amidst developmental transitions.
Purpose of the Study:
- To discuss specific management issues for adolescents with diabetes.
- To highlight challenges faced by diabetic patients and their healthcare providers during teenage years.
- To provide insights into optimizing care for this population.
Main Methods:
- Literature review and clinical discussion.
- Analysis of common adolescent behaviors and their impact on diabetes.
- Exploration of psychological and social factors influencing adherence.
Main Results:
- Metabolic control often deteriorates during adolescence due to increased insulin resistance.
- Adolescents may resist supervision and treatment regimens, impacting adherence.
- Risk-taking behaviors, peer pressure, and eating disorders are more prevalent.
Conclusions:
- Maintaining a respectful patient-provider relationship is crucial.
- Encouraging family support and positive reinforcement aids management.
- Addressing risk-taking behaviors and psychological factors is essential for improved outcomes.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...